Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
2.930
+0.070 (2.45%)
At close: Nov 24, 2025, 4:00 PM EST
2.980
+0.050 (1.71%)
After-hours: Nov 24, 2025, 7:45 PM EST
Treace Medical Concepts Market Cap
Treace Medical Concepts has a market cap or net worth of $186.69 million as of November 24, 2025. Its market cap has decreased by -61.48% in one year.
Market Cap
186.69M
Enterprise Value
204.43M
1-Year Change
-61.48%
Ranking
Category
Stock Price
$2.93
Market Cap Chart
Since the IPO on April 23, 2021, Treace Medical Concepts's market cap has decreased from $889.74M to $186.69M, a decrease of -79.02%. That is a compound annual growth rate of -28.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 21, 2025 | 182.23M | -60.68% |
| Dec 31, 2024 | 463.49M | -41.06% |
| Dec 29, 2023 | 786.37M | -38.37% |
| Dec 30, 2022 | 1.28B | 28.74% |
| Dec 31, 2021 | 991.14M | 11.40% |
| Apr 23, 2021 | 889.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |